Publication Cover
Mitochondrial DNA
The Journal of DNA Mapping, Sequencing, and Analysis
Volume 23, 2012 - Issue 2
152
Views
24
CrossRef citations to date
0
Altmetric
Full Length Research Papers

Polymorphisms in genes encoding mt-tRNA in female breast cancer in Poland

&
Pages 106-111 | Received 06 Nov 2011, Accepted 23 Jan 2012, Published online: 07 Mar 2012

References

  • Achilli A, Rengo C, Battaglia V, Pala M, Olivieri A, Fornarino S, Magri C, Scozzari R, Babudri N, Santachiara-Benerecetti AS, Bandelt HJ, Semino O, Torroni A. 2005. Saami and Berbers-an unexpected mitochondrial DNA link. Am J Hum Genet. 76:883–886.
  • Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. 2007. Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 67:4687–4694.
  • Booker LM, Habermacher GM, Jessie BC, Sun QC, Baumann AK, Amin M, Lim SD, Fernandez-Golarz C, Lyles RH, Brown MD, Marshall FF, Petros JA. 2006. North American white mitochondrial haplogroups in prostate and renal cancer. J Urol. 175:468–472.
  • Canter JA, Kallianpur AR, Parl FF, Millikan RC. 2005. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 65:8028–8033.
  • Covarrubias D, Bai RK, Wong LJ, Leal SM. 2008. Mitochondrial DNA variant interactions modify breast cancer risk. J Hum Genet. 53:924–928.
  • Crimi M, Del Bo R, Galbiati S, Sciacco M, Bordoni A, Bresolin N, Comi PG. 2003. Mitochondrial A12308G polymorphism affects clinical features in patients with single mtDNA macrodeletion. Eur J Hum Genet. 11:896–898.
  • Czarnecka AM, Krawczyk T, Zdrozny M, Lubiński J, Arnold RS, Kukwa W, Scińska A, Golik P, Bartnik E, Petros JA. 2010. Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat. 121:511–518.
  • Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN. 2007. Mitochondrial DNA G10398A polymorphism imparts maternal haplogroup N a risk for breast and esophageal cancer. Cancer Lett. 8:249–255.
  • Gal A, Pentelenyi K, Remenyi V, Pal Z, Csanyi B, Tomory G, Rasko I, Molnar MJ. 2010. Novel heteroplasmic mutation in the anticodon stem of mitochondrial tRNALys associated with dystonia and stroke-like episodes. Acta Neurol Scand. 122:252–256.
  • Ghelli A, Porcelli AM, Zanna C, Vidoni S, Mattioli S, Barbieri A, Iommarini L, Pala M, Achilli A, Torroni A, Rugolo M, Carelli V. 2009. The background of mitochondrial DNA haplogroup J increases the sensitivity of Leber's hereditary optic neuropathy cells to 2,5-hexanedione toxicity. PLoS One. 19:e7922.
  • Grasso M, Diegoli M, Brega A, Campana C, Tavazzi L, Arbustini E. 2001. The mitochondrial DNA mutation T12297C affects a highly conserved nucleotide of tRNA(Leu(CUN)) and is associated with dilated cardiomyopathy. Eur J Hum Genet. 9:311–315.
  • Hall TA. 1999. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser. 41:95–98.
  • Helm M, Brulé H, Friede D, Giegé R, Pütz D, Florentz C. 2000. Search for characteristic structural features of mammalian mitochondrial tRNAs. RNA. 6:1356–1379.
  • Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE, Howell N. 2002. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences from the major African, Asian, and European haplogroups. Am J Hum Genet. 70:1152–1171.
  • Hosgood HD, Liu CS, Rothman N, Weinstein SJ, Bonner MR, Shen M, Lim U, Virtamo J, Cheng WL, Albanes D, Lan Q. 2010. Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. Carcinogenesis. 31:847–849.
  • Huang X, Madan A. 1999. CAP3: A DNA sequence assembly program. Genome Res. 9:868–877.
  • Kivisild T, Shen P, Hall DP, Do B, Sung R, Davis K, Passarino G, Underhill PA, Scharfe C, Torroni A, Scozzari R, Modiano D, Coppa A, de Knijff P, Feldman M, Cavalli-Sforza LL, Oefner PJ. 2006. The role of selection in the evolution of human mitochondrial genomes. Genetics. 172:373–387.
  • Koilkonda RD, Guy J. 2011. Leber's hereditary optic neuropathy-gene therapy: From benchtop to bedside. J Ophthalmol. 2011:179412.
  • Lehtonen MS, Moilanen JS, Majamaa K. 2003. Increased variation in mtDNA in patients with familial sensorineural hearing impairment. Hum Genet. 113:220–227.
  • Maniura-Weber K, Helm M, Engemann K, Eckertz S, Mollers M, Schauen M, Hayrapetyan A, von Kleist-Retzow JC, Lightowlers RN, Bindoff LA, Wiesner RJ. 2006. Molecular dysfunction associated with the human mitochondrial 3302A>G mutation in the MTTL1 (mt-tRNALeu(UUR)) gene. Nucleic Acids Res. 34:6404–6415.
  • McFarland R, Elson JL, Taylor RW, Howell N, Turnbull DM. 2004. Assigning pathogenicity to mitochondrial tRNA mutations: When ‘definitely maybe’ is not good enough. Trends Genet. 20:591–596.
  • Mishmar D, Ruiz-Pesini E, Golik P, Macaulay V, Clark AG, Hosseini S, Brandon M, Easley K, Chen E, Brown MD, Sukernik RI, Olckers A, Wallace DC. 2003. Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci USA. 100:171–176.
  • Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallacem DC. 2005. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA. 102:719–724.
  • Qu F, Liu X, Zhou F, Yang H, Bao G, He X, Xing J. 2011. Association between mitochondrial DNA content in leukocytes and colorectal cancer risk. Cancer. 117:3148–3155.
  • Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC. 2004. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science. 303:223–226.
  • Ruppert V, Nolte D, Aschenbrenner T, Pankuweit S, Funck R, Maisch B. 2004. Novel point mutations in the mitochondrial DNA detected in patients with dilated cardiomyopathy by screening the whole mitochondrial genome. Biochem Biophys Res Commun. 318:535–543.
  • Sakr WA. 2004. Epidemiology of prostate cancer and its precursors. Modern Pathol. 10 317: 1–10.
  • Tan DJ, Bai RK, Wong LJC. 2002. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 62:972–976.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.